Ten‐Year Medicare Use and Spending on the 10 Drugs Selected for Negotiation Under the Inflation Reduction Act
Saved in:
Main Authors: | Mohammed Essa, Joseph S. Ross, Sanket S. Dhruva, Nihar R. Desai, Erica S. Spatz, Kamil F. Faridi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-02-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.124.034682 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Common spine codes are reimbursed 13% less by Medicaid compared to Medicare, ranging from 46% to 160% by state
by: Adam P. Henderson, BS, et al.
Published: (2025-03-01) -
Reducing men’s health drug costs: exploring the impact of the Mark Cuban Cost Plus Drug Company model on Medicare savings
by: Adam Khan, et al.
Published: (2024-12-01) -
Incidence and Prevalence of Alzheimer’s Disease in Medicare Beneficiaries
by: Haixin Zhang, et al.
Published: (2024-12-01) -
Effects of Pharmacotherapy Training Course on Improving the Drug Prescription Skills of Medical Students: A Pharmacy-based Intervention
by: Fatemeh Taheri Asl, et al.
Published: (2024-12-01) -
Analysis of the food and medicines provision in the northern regions of the USA and Canada
by: A. S. Moiakunova
Published: (2023-03-01)